Stock Price Forecast

Aug. 17, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Aridis Pharmaceuticals Inc chart...

About the Company

aridis is a privately held infectious diseases focused company in san jose, ca, usa. aridis’ advanced formulation and delivery technologies are combined with proprietary products portfolio to create potent drug candidates that are packaged into convenient to administer, "ready-to-use" formats.

Exchange

OTC MARKETS

Website

aridispharma.com

$1M

Total Revenue

17

Employees

$6M

Market Capitalization

-0.11

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ARDS News

Aridis Pharmaceuticals Inc ARDS

4d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Wolfgang Dummer's Net Worth

1mon ago, source: Benzinga.com

This is based on reported shares across multiple companies, which include RIGEL PHARMACEUTICALS INC, Aridis Pharmaceuticals, Inc., and ALPINE IMMUNE SCIENCES, INC.. Attention insiders: Dive deeper ...

Horizon Tech Finance Stock (NASDAQ:HRZN), Quotes and News Summary

1mon ago, source: Benzinga.com

Here Are Other Stocks Moving In Wednesday's Mid-Day Session Gainers Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) shares jumped 143% to $0.45 after the company announced it received agreement from ...

Acurx Pharmaceuticals, Inc. (ACXP)

1d ago, source: Yahoo Finance

Staten Island, New York--(Newsfile Corp. - March 21, 2024) - Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) announced today that it will be presenting at The 14th Annual LD Micro Invitational at the ...

ABOS Acumen Pharmaceuticals, Inc.

7h ago, source: Seeking Alpha

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer’s disease. The company focuses on advancing a targeted ...

Elite Pharmaceuticals, Inc. (ELTP)

1d ago, source: Yahoo Finance

Elite Pharmaceuticals, Inc. (PNK:ELTP) Q3 2024 Earnings Call Transcript February 15, 2024 Elite Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the ...

XENE Xenon Pharmaceuticals Inc.

1d ago, source: Seeking Alpha

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the development of therapeutics to treat patients with neurological disorders in Canada. Its clinical ...

Aridis Pharmaceuticals Inc ARDS

4d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Aridis Pharmaceuticals Inc. (ARDS)

5y ago, source: Nasdaq

*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...

Aridis Pharmaceuticals Inc. Common Stock (ARDS)

5y ago, source: Nasdaq

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

Aridis Pharmaceuticals, Inc. (ARDS)

2mon ago, source: Yahoo Finance

*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...